Proactive Investors One2One Investor Forum - London

Netscientific PLC | discoverIE Group plc | Itaconix Plc | Realm Therapeutics plc

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception. Details on the presenting companies can be found below.

This event is suitable for the following:

Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

The event is not suitable for people pursuing commercial opportunities.

discoverIE Group plc


discoverIE (LSE: DSCV) is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

We provide application-specific components to original equipment manufacturers (OEMs) internationally. With our in-house component design capability, we assist customers in designing a component to meet their requirements from our wide range of products, which we then supply for their production needs.

Market: LSE
52-week High/Low: 380.00p / 210.00p
Market Cap: 261.64M

View full company profile

Itaconix Plc


Itaconix plc aims to be a leader in functional polymers that improve the safety, performance and sustainability of our customer’s products.

Itaconix designs and manufactures proprietary specialty polymers to meet customer’s needs. We are the world leader in polymers from itaconic acid, combining the versatile chemistry of itaconic acid with breakthrough economics. We are establishing a pipeline of polymers that compete on unique functionality and cost advantages in home care and industrial markets and personal care. Itaconix also uses its specialty polymers to encapsulate sensitive ingredients that are used in everyday products, examples include bleach actives and fragrances.

Itaconix’s open and collaborative style has successfully led to its technology and products being adopted by leading industry players such as Solvay, Croda and AkzoNobel.

Our polymers are used in a growing number of consumer and industrial products to reduce cost, improve performance, and reduce impact on the environment. We make polymers for better living.

Market: AIM
52-week High/Low: 35.00p / 15.02p
Market Cap: 12.40M

View full company profile

Netscientific PLC


NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.

NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.

NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.

Market: AIM
52-week High/Low: 74.70p / 36.00p
Market Cap: 49.02M

View full company profile

Realm Therapeutics plc


Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes their formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas including Dermatology and Ophthalmology.

Market: LSE
52-week High/Low: 45.00p / 27.41p
Market Cap: 43.13M

View full company profile
Copyright ©, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated.